Article Text

PDF
ASSA14-01-01 The value of plasma lipoprotein- associated phospholipase A2 (Lp-PLA2) levels in the diagnosis of suspected coronary heart disease (CHD)
  1. X Yanmin,
  2. C Zhanqian
  1. Cardiology Department, The Second Hospital of Tianjin Medical University, Tianjin 300211, China

Abstract

Objective To investigate the value of plasma lipoprotein- associated phospholipase A2 (Lp-PLA2) levels in the diagnosis of suspected coronary heart disease (CHD) subjects.

Methods Enrolled suspected CHD subjects (n = 73) and health control (n = 31), 104 in total. Coronary angiography (CAG) was performed in 73 patients who suspected as having CHD. According to the result of CAG, patients were divided into CHD group (n = 52) and non-CHD group (n = 21) and control group (n = 31). The CHD group was further divided into subgroups according to whether need Percutaneous Coronary Intervention (PCI), including PCI group (n = 25) and non-PCI group (n = 27). The plasma levels of low density lipoprotein –cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG), Lp-PLA2, high density lipoprotein-cholesterol (HDL-C) were measured in all groups and the results were compared and analysed. Using logistic regression analysis the relationships between each variables and CHD.

Results The plasma level of Lp-PLA2 was higher in CHD group than that both in non-CHD group and control group (p < 0.001 and < 0.05, respectively). There was no significant difference in the level of Lp-PLA2 between non-CHD group and control group. HDL-C levels was lower in CHD group than that both in non-CHD group and control group (p < 0.021 and < 0.014, respectively). There was no significant difference between non-CHD group and control group. Logistic regression analysis revealed that the plasma level of Lp-PLA2 is the independent risk factor to CHD (p = 0.002, OR 1.011), HDL is the protect factor to CHD (p = 0.021, OR 0.045). However, there was no significant difference of the plasma level of Lp-PLA2 and HDL-C between PCI group and non-PCI group (p = 0.244 and 0.716, respectively).

Conclusion The plasma level of Lp-PLA2 is higher in CHD patients, there was significant prediction value to test plasma Lp-PLA2 level in suspected CHD patients for their diagnosis.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.